Albemarle Corporation: Mixed — EPS $2.58, Revenue $1.55B

ALBAlbemarle Corporation•Q3 2026•Nov 04, 2026, 4:19 PM EST
4
Mixed ResultQ3 2026 · After-market

Did Albemarle Corporation (ALB) beat earnings today?

@trystockwhiz

It was a mixed report for Q3 2026 — Albemarle Corporation (ALB) beat on EPS but missed on revenue.

Earnings Per Share+1.98% surprise
$2.58Actual
Expected: $2.53
vs. year ago +1457.9%
Total Revenue-1.08% surprise
$1.55BActual
Expected: $1.57B
vs. year ago +18.8%
Released Nov 04 · 4:15 PM ET

Earning Report

MetricQ3 2026Q3 2025YoY Change %
Revenue$1.55B$1.31B+18.8%
Revenue detail — reported lines
└─Energy Storage$1.12B$708.75M+57.9%
└─Specialties$388.61M$344.96M+12.7%
GAAP Basic EPS$2.16-$1.72-
GAAP Diluted EPS$2.15-$1.72-
Adjusted Diluted EPS$2.58-$0.19-
Net Income$296.75M($160.69M)-

Financial Outlook / Guidance

FY 2026E Outlook

Average lithium market price
Guidance
FY 2025 avg: ~$10/kg LCE; Q1 2026 avg: ~$20/kg LCE; 2021-2025 avg: ~$30/kg LCE
Expected
—
Net sales
Guidance
FY 2025 avg: $4.1-$4.3B; Q1 2026 avg: $5.7-$6.0B; 2021-2025 avg: $7.5-$7.8B
Expected
$6.07BBeat +33260.79%
Adjusted EBITDA
Guidance
FY 2025 avg: $0.9-$1.0B; Q1 2026 avg: $2.4-$2.6B; 2021-2025 avg: $4.2-$4.4B
Expected
—
Sales volumes
Guidance
225-235 kilotons LCE
Expected
—
Energy Storage Net sales
Guidance
FY 2025 avg: $2.5-$2.6B; Q1 2026 avg: $4.0-$4.2B; 2021-2025 avg: $5.9-$6.1B
Expected
—
Energy Storage Adjusted EBITDA
Guidance
FY 2025 avg: $0.7-$0.8B; Q1 2026 avg: $2.1-$2.3B; 2021-2025 avg: $3.9-$4.1B
Expected
—
Equity in net income
Guidance
FY 2025 avg: $0.2-$0.3B; Q1 2026 avg: $0.6-$0.7B; 2021-2025 avg: $1.0-$1.1B
Expected
—
Specialties net sales
Guidance
$1.4-$1.6B
Expected
—
Specialties adjusted EBITDA
Guidance
$350-$375M
(prev. $275-$325M
Expected
—
Capital expenditures
Guidance
$300-$350M
(prev. ~$500M
Expected
—
Depreciation and amortization
Guidance
$660-$680M
Expected
—
Corporate adjusted EBITDA
Guidance
-$20-$20M
Expected
—
Interest and financing expenses
Guidance
$120-$140M
Expected
—
Weighted-average common shares outstanding
Guidance
~136M
Expected
—

Business Highlights

  • ➤Delivered more than $150 million in year-to-date run-rate cost and productivity improvements.
  • ➤Talison’s CGP3 achieved 30 days of nameplate performance in September.
  • ➤Global lithium demand rose 48% year-to-date through August, driven by EVs and energy storage.
  • ➤Jordan Bromine Company achieved record quarterly production.
  • ➤Wodgina volumes are expected to partially offset the delayed Talison CGP3 ramp.
  • ➤Talison CGP3 ramp was delayed following a June 9 fire.
  • ➤Albemarle sold a controlling stake in Ketjen’s refining catalyst solutions business.
  • ➤Refining catalyst earnings are now classified as equity income in Corporate.
  • ➤Company plans to prioritize high-return organic growth using its advantaged resource base.
  • ➤Specialties outlook cites demand led by semiconductors, oil and gas, flame retardants and pharmaceuticals.

Management Commentary

Kent Masters, Chairman and CEO

“Albemarle delivered another solid quarter, reflecting disciplined execution across the enterprise. In Specialties, improved pricing and sustained progress on cost and productivity initiatives support an additional increased outlook for the year. Global lithium demand is up 48% year-to-date though August, driven by both electric vehicles and energy storage, reinforcing our confidence in the long-term outlook for the industry. We will continue to prioritize high-return organic growth by leveraging our advantaged resource base, capital spending efficiency, and financial flexibility.”